Target intelligence / Profile preview

RNA, U6 small nuclear 329, pseudogene (RNU6-329P)

Target
RNU6-329P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

**RNA, U6 small nuclear 329, pseudogene (RNU6-329P)** is a human pseudogene related to the functional U6 small nuclear RNA (snRNA) gene family[4][7]. U6 snRNA is a highly conserved component of the spliceosome, which is essential for the removal of introns from pre-mRNA during nuclear pre-mRNA splicing[1][3]. The designation "pseudogene" indicates that RNU6-329P resembles the sequence of U6 snRNA genes but lacks the capacity to produce a functional snRNA product due to mutations or truncations[5]. Most pseudogenes, including RNU6-329P, are generally considered non-functional remnants of gene duplication or retrotransposition events[6]. Some pseudogenes have regulatory roles such as serving as decoys for microRNAs (miRNA sponge), producing small interfering RNAs, or affecting gene regulation at the RNA level, but there is no evidence that RNU6-329P has these functions. There are no known drugs, biomarkers, or therapeutic relevance linked to RNU6-329P. Its main importance is as a member of the large set of U6 snRNA pseudogenes spread throughout the genome[5][6][7].

Other names
RNU6-329P
02

Biological functions

None (pseudogene; presumed to lack biological function)Pseudogenes sometimes involved in regulation via RNA-based mechanisms (see below)
03

Disease associations

Other (no direct disease relevance reported for RNU6-329P; some pseudogenes can act as competitive endogenous RNAs or be transcriptionally active in cancer, but there is no direct evidence for this specific gene[6])

Beyond the preview

Go deeper on RNA, U6 small nuclear 329, pseudogene (RNU6-329P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 329, pseudogene (RNU6-329P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call